APOE and glioblastoma: Although active ligands such as apolipoprotein E (ApoE) peptide can facilitate BBB crossing and tumor uptake of nanomedicines through specific ligand-receptor interactions21,22, infiltration from blood vessels into GBM tumor tissue and to distal tumor cells remains largely inefficient for bulk nanoparticles.